Design, synthesis and in vitro cytotoxicity studies of novel pyrrolo[2,1][1,4] benzodiazepine-glycosylated pyrrole and imidazole polyamide conjugates

被引:29
作者
Kumar, R [1 ]
Lown, JW [1 ]
机构
[1] Univ Alberta, Dept Chem, Edmonton, AB T6G 2G2, Canada
关键词
D O I
10.1039/b306685a
中图分类号
O62 [有机化学];
学科分类号
070303 ; 081704 ;
摘要
The design, synthesis and biological evaluation of novel pyrrolo [2,1][1,4] benzodiazepine-water insoluble 31 - 38 and water soluble 39 - 46 glycosylated pyrrole and imidazole polyamide conjugates are described that involved mercuric chloride mediated cyclization of the corresponding amino diethyl thioacetals. The compounds were prepared with varying numbers of pyrrole and imidazole containing polyamides and incorporating glucose moieties in order to improve the water solubility of PBD-polyamide conjugates and probe the structural requirements for optimal in vitro antitumor activity. These compounds were tested against a panel of 60 human cancer cells by the National Cancer Institute, and demonstrated that the water soluble PBD-polyamide compounds exhibited a higher level of cytotoxic activity than the existing natural and synthetic pyrrolo [2,1-c][ 1,4] benzodiazepines. The cytotoxic activities of these compounds dramatically increase after hydrolysis of their acetylated counterparts. The activity data summarized in Table 1 and Table 2 show that the solubility of the PBD-polyamides and also the type of heterocycle play important roles influencing the cytotoxic activity of the PBD-polyamide conjugates. The PBD-glycosylated polyamide ( water soluble) conjugates 39 - 46 are highly cytotoxic against many human cancer cell lines in comparison with the PBD-polyamide (water insoluble version) conjugates.
引用
收藏
页码:3327 / 3342
页数:16
相关论文
共 32 条
[21]  
Kumar R, 2002, HETEROCYCL COMMUN, V8, P115
[22]   Synthesis and cytotoxicity on sensitive and doxorubicin-resistant cell lines of new pyrrolo[2,1-c][1,4]benzodiazepines related to anthramycin [J].
Langlois, N ;
Rojas-Rousseau, A ;
Gaspard, C ;
Werner, GH ;
Darro, F ;
Kiss, R .
JOURNAL OF MEDICINAL CHEMISTRY, 2001, 44 (22) :3754-3757
[23]  
LOWN JW, 1995, Patent No. 4912199
[24]   Highly potent synthetic polyamides, bisdistamycins, and lexitropsins as inhibitors of human immunodeficiency virus type 1 integrase [J].
Neamati, N ;
Mazumder, A ;
Sunder, S ;
Owen, JM ;
Tandon, M ;
Lown, JW ;
Pommier, Y .
MOLECULAR PHARMACOLOGY, 1998, 54 (02) :280-290
[25]   A QUANTITATIVE ASSAY TO MEASURE THE RELATIVE DNA-BINDING AFFINITY OF PYRROLO[2,1-C][1,4]BENZODIAZEPINE (PBD) ANTITUMOR ANTIBIOTICS BASED ON THE INHIBITION OF RESTRICTION-ENDONUCLEASE BAMHI [J].
PUVVADA, MS ;
HARTLEY, JA ;
JENKINS, TC ;
THURSTON, DE .
NUCLEIC ACIDS RESEARCH, 1993, 21 (16) :3671-3675
[26]   Inhibition of bacteriophage T7 RNA polymerase in vitro transcription by DNA-binding pyrrolo[2,1-c][1,4]benzodiazepines [J].
Puvvada, MS ;
Forrow, SA ;
Hartley, JA ;
Stephenson, P ;
Gibson, I ;
Jenkins, TC ;
Thurston, DE .
BIOCHEMISTRY, 1997, 36 (09) :2478-2484
[27]  
Reddy BSP, 1999, SYNLETT, P1112
[28]   Synthetic DNA minor groove-binding drugs [J].
Reddy, BSP ;
Sondhi, SM ;
Lown, JW .
PHARMACOLOGY & THERAPEUTICS, 1999, 84 (01) :1-111
[29]  
Reddy BSP, 2000, ANTI-CANCER DRUG DES, V15, P225
[30]   Synthesis of sequence-selective C8-linked pyrrolo[2,1-c][1,4]benzodiazepine DNA interstrand cross-linking agents [J].
Thurston, DE ;
Bose, DS ;
Thompson, AS ;
Howard, PW ;
Leoni, A ;
Croker, SJ ;
Jenkins, TC ;
Neidle, S ;
Hartley, JA ;
Hurley, LH .
JOURNAL OF ORGANIC CHEMISTRY, 1996, 61 (23) :8141-8147